Cargando…
Screening and characterization of myositis‐related autoantibodies in COVID‐19 patients
An efficient host immune response against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2, COVID‐19) appears to be crucial for controlling and resolving this viral infection. However, many studies have reported autoimmune characteristics in severe COVID‐19 patients. Moreover, clinical ob...
Autores principales: | Teo, Kai‐Fa, Chen, Der‐Yuan, Hsu, Jeh‐Ting, Lai, Yi‐Hua, Chang, Ching‐Kun, Hsueh, Po‐Ren, Lan, Joung‐Liang, Hsu, Jye‐Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841303/ https://www.ncbi.nlm.nih.gov/pubmed/36271647 http://dx.doi.org/10.1111/cts.13434 |
Ejemplares similares
-
Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies
por: Okiyama, Naoko, et al.
Publicado: (2019) -
Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease
por: Wu, Kun-Chang, et al.
Publicado: (2021) -
Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014) -
Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020) -
Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)